130 Participants Needed

Functional Assessment + X-Ray Imaging for Pelvic Sarcoma

VO
Overseen ByValerae O Lewis, BS,MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on improving surgery outcomes for individuals with pelvic sarcomas, a type of cancer in the pelvic bone. By using personalized computer models to simulate walking, doctors aim to plan better surgeries and rehabilitation, helping patients walk more comfortably after treatment. Participants will either have their walking assessed with motion capture and X-rays (X-Ray Imaging) or provide past medical imaging and therapy records. Suitable candidates for this trial include those who have had or will have a specific pelvic surgery at UT MD Anderson Cancer Center. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance surgical outcomes and rehabilitation for future patients.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these methods are safe for improving surgical planning and rehabilitation in pelvic sarcoma patients?

Research shows that the treatments in this trial are generally safe and well-tolerated. Here's a breakdown:

1. **Functional Assessment and Patient-Specific Walking Models**: These non-invasive methods enhance patients' walking ability post-surgery. Studies have shown these models can predict walking ability without causing harm. They function like simulations or virtual tests tailored to each patient.

2. **X-Ray Imaging**: X-rays, commonly used in medicine, allow doctors to see inside the body. Although they involve radiation, the amount is very low. Research on X-ray use for sarcoma (a type of cancer) indicates they are safe when used correctly. The radiation risk is minimal.

Overall, these treatments are safe and designed to help, not harm.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative ways to assess and understand pelvic sarcoma treatment outcomes. Unlike traditional methods that might rely solely on standard imaging techniques, this trial uses functional assessments combined with advanced technologies like optical motion capture and bi-plane dynamic X-ray imaging. This approach provides a more comprehensive view of how patients recover their walking function before and after surgery. By leveraging patient-specific computational walking models, researchers hope to gain deeper insights into individual recovery patterns, potentially leading to more personalized and effective treatment plans in the future.

What evidence suggests that these methods are effective for improving surgical planning and rehabilitation in pelvic sarcoma patients?

Research has shown that personalized computer models can enhance surgery and recovery for patients with pelvic sarcoma, a type of cancer. These models assist doctors in selecting the best surgical methods to improve walking ability post-surgery. In this trial, participants in the supportive care arm will undergo walking function assessment using optical motion capture and bi-plane dynamic X-ray imaging before and after hemipelvectomy. Tests of movement and X-ray images also clarify how surgery impacts walking and guide personalized recovery plans. Overall, these tools aim to improve recovery and walking outcomes for those undergoing pelvic sarcoma surgery.12678

Who Is on the Research Team?

VO

Valerae O. Lewis

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

This trial is for adults who have or will undergo internal hemipelvectomy at UT MD Anderson Cancer Center to treat pelvic sarcomas. It's not for those with certain hip conditions, previous significant hip injuries/surgeries, recent surgeries affecting movement, pregnant/nursing women, or individuals with specific metal implants.

Inclusion Criteria

I am scheduled for or have had a surgery to remove part of my pelvis at UT MD Anderson.

Exclusion Criteria

Persons with a pacemaker, hearing aid, aneurysm clips or artificial heart valves, and other forms of loose metal implants will be excluded from the study as assessed by a pre-MRI questionnaire administered by the MRI technician at the time of the scan
I have had surgery or a major injury to my hip.
Pregnant women or women nursing an infant
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-Surgery Assessment

Patients undergo walking function assessment using optical motion capture and bi-plane dynamic X-ray imaging pre-hemipelvectomy

1-2 weeks
1 visit (in-person)

Surgery and Immediate Post-Surgery

Patients receive hemipelvectomy surgery and immediate post-surgery care

1 week

Post-Surgery Assessment

Patients undergo walking function assessment using optical motion capture and bi-plane dynamic X-ray imaging post-hemipelvectomy

1-2 weeks
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Functional Assessment
  • Patient-Specific Computational Walking Models
  • X-Ray Imaging
Trial Overview The study is developing personalized computational models to improve surgical planning and rehabilitation for better walking function after surgery in patients with pelvic sarcomas. It involves functional assessments and X-ray imaging to tailor treatment approaches.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Supportive care (walking function test, X-ray)Experimental Treatment2 Interventions
Group II: Retrospective GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

A new method combining a material testing machine with a 3D video motion capturing system successfully measures the dynamic 3D deformation of pelvic bones, achieving a measurement accuracy of ± 0.036 mm, which is crucial for designing better orthopedic implants.
This innovative setup allows for more realistic datasets that can improve the understanding of material characteristics in anatomical specimens, leading to enhanced biomechanical modeling and potentially more effective implant designs.
3D video-based deformation measurement of the pelvis bone under dynamic cyclic loading.Göpfert, B., Krol, Z., Freslier, M., et al.[2021]
In a study of 5 patients who underwent surgery for pelvic chondrosarcoma, all patients reported no pain and demonstrated good functional outcomes in work and gait, indicating effective recovery post-surgery.
The study found a significant relationship between hip extension strength and various functional measures, such as gait velocity and weight bearing, suggesting that strengthening hip muscles is crucial for improving mobility after surgery.
A follow-up examination of the function of the lower extremity after pelvic tumour extirpation including the acetabular ring.Olsson, E.[2008]
A study involving seven patients who underwent various types of pelvic tumor resections showed that using a hip stabilizer significantly improved their walking speed and other gait parameters, indicating better control over the affected limb.
The findings suggest that a biomechanical approach, such as using a hip stabilizer, can enhance post-operative mobility and gait function in patients after pelvic tumor surgery.
The effect of an external hip joint stabiliser on gait function after surgery for tumours located around the circumference of the pelvis: analysis of seven cases of internal hemipelvectomy or proximal femur resection.Akiyama, T., Saita, K., Ogura, K., et al.[2018]

Citations

Patient-Specific Computational Walking Models in ...This trial studies the development of patient-specific computational walking models to improve the surgical planning and rehabilitation treatment of patients ...
Functional Assessment + X-Ray Imaging for Pelvic SarcomaThis trial studies the development of patient-specific computational walking models to improve the surgical planning and rehabilitation treatment of ...
Changes in walking function and neural control following ...Experimental walking and CT scan data were collected pre- and post-surgery from a single participant with a pelvic sarcoma who received internal hemipelvectomy ...
Changes in Walking Function and Neural Control following ...Experimental walking and CT scan data were collected pre- and post-surgery from a single patient with a pelvic sarcoma who received internal ...
Computational evaluation of psoas muscle influence on ...Computational evaluation of psoas muscle influence on walking function following internal hemipelvectomy with reconstruction
Functional Outcomes and Activity Levels in Patients After ...The aim of this study was to investigate functional outcomes, including sport activity levels, and the impact of tumor grade, resection margins, adjuvant ...
Predicting Post-surgery Walking Function of Pelvis Sarcoma ...In the first technical chapter (Chapter 2), a personalized musculoskeletal model was created to simulate the gait movement of a pelvic sarcoma patient. The ...
Changes in Walking Function and Neural Control following ...These models were used to calculate the patient's pre- and post-surgery joint motions, joint moments, and muscle synergies. The calculated ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security